Trial intelligence / Profile preview

Twice Weekly TP CCRT for Esophageal Cancer

NCT00154804Phase 2Completed

Sponsor
National Taiwan University Hospital
Start
Aug 2001
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of paclitaxel, cisplatin in esophageal cancer, sponsored by National Taiwan University Hospital. Started Aug 2001; status: completed.

02

Drugs

paclitaxelcisplatin
03

Conditions

esophageal cancer

Beyond the preview

Go deeper on NCT00154804.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00154804.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call